Why do you consume cannabis?
 
Home arrow Medical Use arrow Medical Cannabis Legislation arrow Cannabis Compound Beats Current Alzheimer's Drugs in Test-Tube Study
Cannabis Compound Beats Current Alzheimer's Drugs in Test-Tube Study PDF Print E-mail
The basic neuroprotective qualities of cannabis have been well established, but doctors are still working out the direct applications. Indications are good for treating conditions ranging from head trauma to Parkinson's. A study on Alzheimer's published in the summer of 2006 is particularly exciting, given the dearth of treatments currently available. THC, the key compound in cannabis, may also be the key to new drugs for Alzheimer's disease. That's because the compound blocks the formation of brain-clogging Alzheimer's plaques better than current Alzheimer's drugs.

The finding - in test-tube studies - comes from the lab of Kim Janda, Ph.D., director of the Worm Institute of Research and Medicine at Scripps Research Institute. "While we are certainly not advocating the use of illegal drugs, these findings offer convincing evidence that THC possesses remarkable inhibitory qualities, especially when compared to Alzheimer's drugs currently available to patients," Janda says in a news release.

"Although our study is far from final, it does show that there is a previously unrecognized molecular mechanism through which THC may directly affect the progression of Alzheimer's disease." Janda's team found that THC blocks an enzyme called acetylcholinesterase, which speeds the formation of amyloid plaque in the brains of people with Alzheimer's disease. The Alzheimer's drugs Aricept and Cognex work by blocking acetylcholinesterase.When tested at double the concentration of THC, Aricept blocked plaque formation only 22% as well as THC, and Cognex blocked plaque formation only 7% as well as THC.

"THC and its analogs may provide an improved [treatment for] both the symptoms and progression of Alzheimer's disease," the researchers conclude.

The findings appear in the Aug. 9, 2006 online edition of the journal Molecular Pharmaceutics, a publication of the American Chemical Society.
 
< Prev   Next >
© 2008 Illinois NORML
Joomla! is Free Software released under the GNU/GPL License.